UK bio firms urge Government to keep biomanufacturing at home

More than 100 UK businesses, investors and organisations delivered a letter to 10 Downing Street on November 17. They want biotechnologies invented in Britain to be scaled, manufactured and commercialised in the country.

The Made by British Bio campaign is led by the Bio-based and Biodegradable Industries Association (BBIA) and the BioRevolution Coalition. Signatories include Croda, Ensus, Xampla and Notpla. The campaign says they represent £4.4 billion in revenues and over 35,000 jobs.

The letter warns that the UK risks losing the benefits of its research. The Government has committed £2 billion over ten years to engineering biology. Even so, signatories cite high capital costs, limited scale-up infrastructure and uncertain markets. They also criticise regulation designed around fossil-based industries.

The campaign says the UK bioeconomy adds around £325 billion in gross value added and supports 6.4 million jobs. It ranks 21st of 28 European countries for growth. With the right support, the campaign estimates the annual contribution could reach £500 billion by 2030.

- Advertisement -
Ad imageAd image

The letter asks for four actions. These are clear ministerial leadership, faster delivery of the £186 million Engineering Biology Infrastructure Programme, fairer treatment of renewable and fossil carbon, and public sector purchasing to create early demand. As a first step, signatories want a cross-government roundtable with ministers, officials, industry leaders and investors.

The letter follows a parliamentary petition signed by more than 1,000 people.

BBIA chief executive Jen Vanderhoven said Britain has invested in science and must now capture the biomanufacturing. Paul Mines, BBIA chair and chief executive of Biome Technologies, said small firms face real barriers. He said they need a level playing field.

Share This Article